Fribourg, Switzerland

Jonas Pollard

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Diagnostic Methods by Jonas Pollard

Introduction

Jonas Pollard is an accomplished inventor based in Fribourg, Switzerland. He has made significant contributions to the field of medical diagnostics, particularly in the detection and quantification of blood-related diseases. His innovative approach utilizes advanced techniques to improve the accuracy and efficiency of diagnostic tests.

Latest Patents

Jonas Pollard holds a patent for a diagnostic method that is suitable for the detection and quantification of blood-related diseases or conditions. This method employs biomarkers, such as hemoglobin and hemozoin, as catalysts in an atom transfer radical polymerization (ATRP) reaction. The reaction is performed above a lower critical solution temperature (LCST) of a polymer, allowing the polymerization process to be tracked by the rate of turbidity formation. The correlation between the rate of turbidity formation and the concentration of the biomarker makes this technique a valuable quantitative method that can be utilized as a point-of-care test in various settings.

Career Highlights

Jonas Pollard is affiliated with the Adolphe Merkle Institute at the University of Fribourg, where he conducts research and develops innovative diagnostic methods. His work has garnered attention for its potential to enhance the detection of blood-related diseases, thereby improving patient outcomes.

Collaborations

Jonas collaborates with notable colleagues, including Nico Bruns and Omar Rifaie Graham, who contribute to the advancement of research in the field of diagnostics. Their combined expertise fosters a collaborative environment that encourages innovation and the development of new technologies.

Conclusion

Jonas Pollard's contributions to diagnostic methods represent a significant advancement in the field of medical technology. His innovative approach to utilizing biomarkers for the detection of blood-related diseases has the potential to revolutionize point-of-care testing.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…